Severe Hypoglycemia Market Insights: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working
Hypoglycemia is a condition in which the blood sugar (glucose) level is lower than the standard range. Hypoglycemia occurs when your blood sugar (glucose) level falls too low for bodily functions to continue. There are several reasons why this can happen.
Severe Hypoglycemia is a very dangerous situation, a person can face fatal medical conditions along with seizures, excessive body sweating, etc. According to the American Diabetes Association Workgroup on Hypoglycemia, Severe Hypoglycemia is defined as “an event requiring the assistance of another person to actively administer carbohydrate, glucagons, or other resuscitative actions. These episodes may be associated with sufficient neuroglycopenia to induce seizure or coma”.
DelveInsight’s “Severe Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Severe Hypoglycemia, historical and forecasted epidemiology as well as the Severe Hypoglycemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Severe Hypoglycemia Market Report:
The prevalence of Diabetes was estimated to be 9.6% over a population of 15 million in high-income cities
In the United States, the prevalence of Severe Hypoglycemia was 30.7 million cases
The death rate due to the was recorded highest in India with 254,555 deaths followed by the United States with 68,558 deaths
According to the research done, it was observed that 34% of gastric bypass patients developed severe hypoglycemia after being given a bolus of sugar
Request a sample for the Report: https://www.delveinsight.com/sample-request/severe-hypoglycemia-market
The symptoms of Severe Hypoglycemia include –
Looks pale than normal
Shakiness in the body
Sweating
Headaches
Hunger or Nausea
Body Fatigue
Irritability or anxiety
Irregular Heartbeats than normal
Severe Hypoglycemia Market
The dynamics of the Severe Hypoglycemia market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as VX-880, Lilly Glucagon, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Severe Hypoglycemia Market Landscape
Severe Hypoglycemia Pipeline Therapies:
Novo Glucagon
VX-880
Lilly Glucagon
Insulin aspart/degludec
Severe Hypoglycemia Pipeline Key Companies:
Vertex Pharmaceuticals
Xeris Pharmaceuticals
Click here to read more about Severe Hypoglycemia Market Outlook 2032
Related Reports:
Severe Hypoglycemia Pipeline
"Severe Hypoglycemia Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Severe Hypoglycemia market. A detailed picture of the Severe Hypoglycemia pipeline landscape is provided, which includes the disease overview and Severe Hypoglycemia treatment guidelines.
Severe Hypoglycemia Epidemiology
DelveInsight's 'Severe Hypoglycemia Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Severe Hypoglycemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Sialidosis Market
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Microsatellite Stable Colorectal Cancer Market
DelveInsight's "Microsatellite Stable Colorectal Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Microsatellite Stable Colorectal Cancer, historical and forecasted epidemiology as well as the Microsatellite Stable Colorectal Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Blood Glucose Monitoring Systems Market
Blood Glucose Monitoring Systems Market By Product Type (Self-Monitoring Blood Glucose Systems And Continuous Glucose Monitoring Systems), By Modality (Wearable And Non-Wearable), By End-User (Hospitals, Home Care Settings, And Others), by geography, is expected to expand at a noteworthy CAGR till 2027 owing to the growing prevalence of diabetes across the globe and technological advancements in the blood glucose monitoring systems.
Chronic Rhinosinusitis Phenotype with Nasal Polyps Market
DelveInsight's "Chronic Rhinosinusitis Phenotype With Nasal Polyps Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Rhinosinusitis Phenotype With Nasal Polyps, historical and forecasted epidemiology as well as the Chronic Rhinosinusitis Phenotype With Nasal Polyps market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Severe Hypoglycemia Market
DelveInsight's "Severe Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Severe Hypoglycemia, historical and forecasted epidemiology as well as the Severe Hypoglycemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Latest Reports by DelveInsight
Comments
Post a Comment